Citation Impact
Citing Papers
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
2017 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
2008
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
1999
Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting
1999
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
2016 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Head and neck squamous cell carcinoma
2020 Standout
Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD
2004
Hepatocellular carcinoma
2003 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma
2015
Abdominal MR: liver and pancreas
1999
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
2006
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Budd–Chiari syndrome: a review by an expert panel
2003
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd–Chiari Syndrome
2006
Long-term portosystemic shunt patency as a determinant of outcome in Budd–Chiari syndrome
2006
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome
2001
Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres
2005
TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience
2003
Radioimmunoguided surgery for patients with liver metastases secondary to colorectal cancer
1998
Antithrombotic Therapy for VTE Disease
2016 Standout
xCell: digitally portraying the tissue cellular heterogeneity landscape
2017 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
The prognostic value of histology in the assessment of patients with Budd–Chiari syndrome
2001
Twenty years of liver transplantation for Budd-Chiari syndrome: A national registry analysis
2007
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy
2002
Immunogenic cell death in cancer and infectious disease
2016 Standout
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases
2004 Standout
Colorectal cancer
2013 Standout
Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors
2008
Prevention of VTE in Nonsurgical Patients
2012 Standout
Vascular disorders of the liver # †
2008 Standout
High incidence of recurrence and hematologic events following liver transplantation for Budd–Chiari syndrome
2005
Arterial and Portal Circulation and Parenchymal Changes in Budd–Chiari Syndrome: A Study in 17 Explanted Livers
2003
Antithrombotic Therapy for VTE Disease
2012 Standout
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Acute Liver Failure
1993
Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
2000
Procedimientos radiológicos intervencionistas, angioplastia y DPPI en el tratamiento del síndrome de Budd-Chiari
2003
Detection of Hepatocellular Carcinoma: Combined T2-Weighted and Dynamic Gadolinium-Enhanced MRI Versus Combined CT During Arterial Portography and CT Hepatic Arteriography
2001
Diagnostic Imaging of Colorectal Liver Metastases with CT, MR Imaging, FDG PET, and/or FDG PET/CT: A Meta-Analysis of Prospective Studies Including Patients Who Have Not Previously Undergone Treatment
2010
Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome
2003
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009
2009
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
1996
Acetaminophen‐induced acute liver failure
2005 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd‐Chiari syndrome†
2005
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders1
2002
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
2017 Standout
Cryosurgery as a treatment for advanced stage hepatocellular carcinoma
1998
Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome
2005
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
1999 Standout
Acute Budd–Chiari syndrome with liver failure: The experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt
2004
Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents
2003
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Combinatorial Strategies for the Induction of Immunogenic Cell Death
2015
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome
2004
The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt
2004
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Food-Related Illness and Death in the United States
1999 Standout
Factor V Leiden related Budd-Chiari syndrome
2001
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
2014
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Pattern of recurrence after hepatic resection for colorectal metastases
1993
Spermidine in health and disease
2018 StandoutScience
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer
2016
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Cancer Genome Landscapes
2013 StandoutScience
Fulminant hepatic failure: Summary of a workshop
1995
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West
2004
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
2002 Standout
Indications for orthotopic liver transplantation in fulminant liver failure
1994
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
2016
Emergency Left Colon Resection for Acute Perforation. Primary Anastomosis or Hartmann’s Procedure? A Case‐matched Control Study
2007
A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions
2012
Resection of colorectal liver metastases
1995 Standout
Works of Guy Zeitoun being referenced
Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2014
Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting
1999
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
2004
MRI of Liver Metastases from Colorectal Cancer vs. CT during Arterial Portography
1993
Preoperative assessment of resectability of hepatic metastases from colonic carcinoma: CT portography vs sonography and dynamic CT.
1992
HETEROTOPIC LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE—A BRIDGE TO RECOVERY
1990
Treatment of mesocaval shunt stenosis with a metallic stent.
1992
Multicentre, randomized clinical trial of primary versus secondary sigmoid resection in generalized peritonitis complicating sigmoid diverticulitis
2000
Pathogenesis and Treatment of Budd-Chiari Syndrome Combined with Portal Vein Thrombosis
2006
Hepatic venous outflow block caused by short-length hepatic vein stenoses
1997
Clinicopathological forms and prognostic index in Budd-Chiari syndrome
2003
High-resolution Genotyping of Chromosome 8 in Colon Adenocarcinomas Reveals Recurrent Break Point But No Gene Mutation in the 8p21 Region
2008
Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography.
1992